References
- Binazzi M, Simonette V. Granuloma annulare, necrobiosis lipoidica, and diabetic disease. Int J Dermatol 1988; 27: 576–9
- Burton J L. Granuloma annulare, rheumatoid nodules and necrobiosis lipoidica. Br J Dermatol 1985; 97(Suppl 15)52–4
- Schwartz M E. Necrobiosis lipoidica and granuloma annulare. Simultaneous occurrence in a patient. Arch Dermatol 1982; 118: 192–3
- Feldman F F. Granuloma annulare and necrobiosis lipoidica in the same patient. Arch Dermatol 1968; 98: 677–8
- Parra V A. Transepidermal elimination in necrobiosis lipoidica. Br J Dermatol 1977; 96: 83–6
- Alegre V A. Winkelmann RK, A new histopathologic feature of necrobiosis lipoidica diabeticorum: lymphoid nodules. J Cutan Pathol 1988; 15: 75–7
- Wenger R M, Payne T G, Schreirer M H. Cyclosporine chemistry, structure-activity relationship and mode of action. Progr Clin Biochem Med 1986; 3: 157–91
- Shevach E M. The effects of cyclosporine A on the immune system. Annu Rev Immunol 1985; 3: 397–423
- Piggato P D, Mozzanica N, Polenghi M M., et al. Cyclosporine A inhibits polymorphonuclear leukocyte chemotaxis in vivo. Transplant Proc 1988; 20(Suppl 4)91–4
- Chaidemenos G CH, Mourellou O, Karakatsanis G. Cyclosporin in the treatment of generalized granuloma annulare. JEADV 1995; 5(Suppl 1)161
- Gupta A K, Ellis C N, Nickoloff B J., et al. Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol 1990; 126: 339–50
- Filotico R, Vena G A, Coviello C, et al. Cyclosporine in the treatment of generalized granuloma annulare. J Am Acad Dermatol 1994; 30: 487–8